ID
13526
Description
Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01824264
Link
https://clinicaltrials.gov/show/NCT01824264
Keywords
Versions (1)
- 2/13/16 2/13/16 -
Uploaded on
February 13, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes Mellitus NCT01824264
Eligibility Type 2 Diabetes Mellitus NCT01824264
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Fpg ≥270 mg/dl (15 mmol/l)
Data type
boolean
Alias
- UMLS CUI [1]
- C0295510
Description
Insulin treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0745343
Description
Metabolic complications
Data type
boolean
Alias
- UMLS CUI [1]
- C1393263
Description
Laboratory test result abnormal
Data type
boolean
Alias
- UMLS CUI [1]
- C0438215
Description
Ecg abnormalities
Data type
boolean
Description
Malignant Neoplasms
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
Child-bearing potential
Data type
boolean
Alias
- UMLS CUI [1]
- C1960468
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01824264
- StudyEvent: Eligibility